Monday Dec 04, 2023

Is Anifrolumab an effective treatment for lupus nephritis?

Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phase II TULIP Lupus Nephritis trial. This in-depth conversation centers on results from a clinical trial where they evaluated the efficacy of intensified anifrolumab treatment in individuals with active lupus nephritis.

 

Read the article: http://dx.doi.org/10.1136/lupus-2023-000910

643134

Version: 20240320